BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35293322)

  • 21. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.
    Lee YG; Jung I; Koo DH; Kang DY; Oh TY; Oh S; Lee SS
    Support Care Cancer; 2019 May; 27(5):1945-1949. PubMed ID: 30218188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
    Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
    Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis.
    Karampinis I; Dionysopoulou A; Galata C; Almstedt K; Grilli M; Hasenburg A; Roessner ED
    Thorac Cancer; 2022 Apr; 13(7):883-888. PubMed ID: 35194945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
    Liu Y; Wang L; Song Q; Ali M; Crowe WN; Kucera GL; Hawkins GA; Soker S; Thomas KW; Miller LD; Lu Y; Bellinger CR; Zhang W; Habib AA; Petty WJ; Zhao D
    Nat Nanotechnol; 2022 Feb; 17(2):206-216. PubMed ID: 34916656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: A Bayesian network meta-analysis of randomized controlled trials.
    Xu YF; Chen YR; Bu FL; Huang YB; Sun YX; Li CY; Sellick J; Liu JP; Qin DM; Liu ZL
    Front Oncol; 2022; 12():942941. PubMed ID: 36203451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
    Sakaguchi H; Ishida H; Nitanda H; Yamazaki N; Kaneko K; Kobayashi K
    Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines.
    Zeng FL; Xiao Z; Wang CQ; Jiang Y; Shan JL; Hu SS; Huang XR; Tang YH; Yao XS; Zhang T; Zeng XT; Feng JH; Xiao X
    Int Immunopharmacol; 2019 Oct; 75():105747. PubMed ID: 31326719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
    Kang M; Zhou L; Lin P
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion.
    Massarelli E; Onn A; Marom EM; Alden CM; Liu DD; Tran HT; Mino B; Wistuba II; Faiz SA; Bashoura L; Eapen GA; Morice RC; Jack Lee J; Hong WK; Herbst RS; Jimenez CA
    Clin Lung Cancer; 2014 Sep; 15(5):379-86. PubMed ID: 24913066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion.
    Fuhong D; Xiang G; Haiying L; Jiangye W; Xueming G; Wenxiao C
    BMC Cancer; 2018 Apr; 18(1):411. PubMed ID: 29649989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tunneled Pleural Catheter for the Treatment of Malignant Pleural Effusion: A Systematic Review and Meta-analysis.
    Kheir F; Shawwa K; Alokla K; Omballi M; Alraiyes AH
    Am J Ther; 2016; 23(6):e1300-e1306. PubMed ID: 25654292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.
    Tamiya M; Tamiya A; Yamadori T; Nakao K; Asami K; Yasue T; Otsuka T; Shiroyama T; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Kawase I; Hirashima T
    Med Oncol; 2013; 30(3):676. PubMed ID: 23925664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of bevacizumab in the management of the patient with malignant pleural effusion: more questions than answers.
    Sabang RL; Gandhiraj D; Fanucchi M; Epelbaum O
    Expert Rev Respir Med; 2018 Feb; 12(2):87-94. PubMed ID: 29235400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer.
    Orlandi E; Mordenti P; Zangrandi A; Cavanna L
    Chemotherapy; 2014; 60(5-6):321-4. PubMed ID: 26279275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
    Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K
    Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iodopovidone pleurodesis for malignant pleural effusions: an updated systematic review and meta-analysis.
    Muthu V; Dhooria S; Sehgal IS; Prasad KT; Aggarwal AN; Agarwal R
    Support Care Cancer; 2021 Aug; 29(8):4733-4742. PubMed ID: 33515303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in pleurodesis for malignant pleural disease.
    Guinde J; Georges S; Bourinet V; Laroumagne S; Dutau H; Astoul P
    Clin Respir J; 2018 Oct; 12(10):2463-2468. PubMed ID: 30252207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis.
    Iyer NP; Reddy CB; Wahidi MM; Lewis SZ; Diekemper RL; Feller-Kopman D; Gould MK; Balekian AA
    Ann Am Thorac Soc; 2019 Jan; 16(1):124-131. PubMed ID: 30272486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion.
    Li Z; Deng J; Yan F; Liu L; Ma Y; Sun J
    Sci Rep; 2023 Jul; 13(1):12071. PubMed ID: 37495659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.